SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature

  • Rico-Fontalvo Jorge, Daza-Arnedo Rodrigo, Cardona-Blanco Maria Ximena, Leal-Martínez Victor, Abuabara-Franco Emilio, Pajaro-Galvis Nehomar, Cabrales Jose, Correa José, Cueto Manuel, Duran Amable, Castellanos Alejandro, Enamorado Javier, Bohórquez José, Uparella Isabella, Zuñiga Julio, Chagui Abraham, Ramos Alfonso, Lara Luis
  • Journal of Clinical Nephrology, August 2020, Heighten Science Publications Corporation
  • DOI: 10.29328/journal.jcn.1001058

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.29328/journal.jcn.1001058